Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Apr;24(4):477-486.
doi: 10.1111/1756-185X.13970. Epub 2020 Sep 24.

Cardiovascular morbidity and mortality in patients with spondyloarthritis: A meta-analysis

Affiliations
Meta-Analysis

Cardiovascular morbidity and mortality in patients with spondyloarthritis: A meta-analysis

Ji Hyoun Kim et al. Int J Rheum Dis. 2021 Apr.

Abstract

Aim: Cardiovascular (CV) risk and mortality associated with spondyloarthritis (SpA) remain controversial. Herein, we performed a meta-analysis of the latest large-scale population-based studies to demonstrate the elevated risk of CV disease and mortality in patients with SpA than in the general population.

Methods: MEDLINE and EMBASE databases were searched systematically for population-based studies published between January 1997 and September 2019. Additional manual literature searches were also performed. All searches and data collection were performed independently by 2 reviewers. We calculated the risks of myocardial infarction (MI), stroke, and all-cause mortality in a meta-analysis and determined the risk ratios (RR) using the Mantel-Haenszel method.

Results: Among the 641 identified articles, 16 articles involving 18 cases met the inclusion criteria for our meta-analysis; these included 12 cases of ankylosing spondylitis, five cases of psoriatic arthritis, and 1 case of undifferentiated SpA. Our meta-analysis revealed a significantly high risk of MI (RR: 1.52; 95% CI: 1.29-1.80) and stroke (RR: 1.21; 95% CI: 1.0-1.47) in patients with SpA than in the general population. However, this increased risk was not significant in terms of all-cause mortality (RR: 1.23; 95% CI: 0.96-1.57).

Conclusions: Our meta-analysis demonstrated that patients with SpA have a significantly increased risks of MI and stroke, but without a significant increase in the all-cause mortality, than that in the general population. The higher risk of CV in patients with SpA than that in the general population indicates the need for strict risk factor correction and disease management.

Keywords: ankylosing spondylitis; mortality; myocardial infarction; psoriatic arthritis; spondyloarthritis; stroke.

PubMed Disclaimer

References

REFERENCES

    1. Ozgocmen S, Khan MA. Current concept of spondyloarthritis: special emphasis on early referral and diagnosis. Curr Rheumatol Rep. 2012;14:409-414.
    1. Burgos-Vargas R. The assessment of the spondyloarthritis international society concept and criteria for the classification of axial spondyloarthritis and peripheral spondyloarthritis: a critical appraisal for the pediatric rheumatologist. PediatrRheumatol Online J. 2012;10:14.
    1. Shen J, Shang Q, Tam LS. Targeting inflammation in prevention of cardiovascular disease in patients with inflammatory arthritis. Transl Res. 2016;167:138-151.
    1. Castaneda S, Nurmohamed MT, Gonzlez-Gay MA. Cardiovascular disease in inflammatory rheumatic disease. Best Pract Res Clin Rheumatol. 2016;30:851-869.
    1. Kaine J, Song X, Kim G, Hur P, Palmer JB. Higher incidence rates of comorbidities in patients with psoriatic arthritis compared with the general population using U.S. administrative claim data. J Manag Care Spec Pharm. 2019;25:122-132.

MeSH terms

LinkOut - more resources